Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Public ClinicalTrials.gov record NCT01522443. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Controlled Trial of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Study identification
- NCT ID
- NCT01522443
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Exelixis
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Interventions
- cabozantinib Drug
- mitoxantrone Drug
- prednisone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2012
- Primary completion
- Sep 30, 2014
- Completion
- Jan 12, 2015
- Last update posted
- May 22, 2018
2012 – 2015
United States locations
- U.S. sites
- 49
- U.S. states
- 32
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Scottsdale | Arizona | 85258 | — |
| Not listed | La Jolla | California | 92093 | — |
| Not listed | Los Angeles | California | 90024 | — |
| Not listed | Los Angeles | California | 90073 | — |
| Not listed | Marina del Rey | California | 90292 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Santa Barbara | California | 93105 | — |
| Not listed | Stanford | California | 94305 | — |
| Not listed | Aurora | Colorado | 80012 | — |
| Not listed | Littleton | Colorado | 80122 | — |
| Not listed | Washington D.C. | District of Columbia | 20037 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Athens | Georgia | 30607 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Westwood | Kansas | 66025 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Baltimore | Maryland | 21231 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Minneapolis | Minnesota | 55455 | — |
| Not listed | Tupelo | Mississippi | 38801 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Omaha | Nebraska | 68198 | — |
| Not listed | Las Vegas | Nevada | 89109 | — |
| Not listed | New Brunswick | New Jersey | — | — |
| Not listed | Buffalo | New York | 14263 | — |
| Not listed | New York | New York | 10019 | — |
| Not listed | New York | New York | 10022 | — |
| Not listed | New York | New York | 10065 | — |
| Not listed | Chapel Hill | North Carolina | 27516 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Raleigh | North Carolina | 27607 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Pittsburgh | Pennsylvania | 15232 | — |
| Not listed | Watertown | South Dakota | 57201 | — |
| Not listed | Memphis | Tennessee | 38120 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Round Rock | Texas | 78681 | — |
| Not listed | Salt Lake City | Utah | 84112 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Seattle | Washington | 98104 | — |
| Not listed | Madison | Wisconsin | 53705 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01522443, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2018 · Synced Apr 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01522443 live on ClinicalTrials.gov.